Skip to main content

Table 3 HCCs with CR as per mRECIST with recurrence versus no recurrence

From: Value of computed tomography-based lipiodol retention pattern in the assessment of hepatocellular carcinoma complete response following conventional transarterial chemoembolization

 

Recurrence (N = 13)

No recurrence (N = 17)

p value

AFP ng/ml ± SD (range)

743 ± 179 (476–960)

706 ± 144 (440–952)

0.534

HCC size (mm) ± SD (range)

34.69 ± 11.19

20–60

23.59 ± 9.93

13—51

0.008

HCC location

  

0.346

 Right lobe

7 (53.8%)

12 (70.6%)

 

 Left lobe

6 (46.2%)

5 (29.4%)

 

Capsule appearance

  

0.013

 Capsulated

5 (38.5%)

14 (82.4%)

 

 Non-capsulated

8 (61.5%)

3 (17.6%)

 

cTACE procedure

  

0.012

 Selective

9 (69.2%)

4 (23.5%)

 

 Superselective

4 (30.8%)

13 (76.5%)

 
  1. The statistical methods of Chi-square test and independent t-test were employed to analyze discrete and continuous variables, respectively
  2. AFP alpha-fetoprotein, HCC hepatocellular carcinoma, SD standard deviation, cTACE conventional transarterial chemoembolization